Crinetics Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	110.9	264.55	54.9	32.67	200.7	93.09
Short-Term Investments	981.39	1,090	503.66	301.75	133.01	77.79
Cash & Short-Term Investments	1,092	1,354	558.56	334.43	333.71	170.88
Cash Growth	26.62%	142.42%	67.02%	0.21%	95.29%	44.33%
Other Receivables	-	8.47	9.26	2.9	1.48	1.83
Receivables	-	8.47	9.26	2.9	1.48	1.83
Prepaid Expenses	28.48	10.43	4.56	3.51	7.2	1.72
Restricted Cash	0.5	0.5	-	-	-	-
Other Current Assets	-	1.92	1.78	4.36	2.34	3.06
Total Current Assets	1,121	1,375	574.15	345.18	344.72	177.49
Property, Plant & Equipment	55.52	55.58	57.43	4.99	4.72	5.41
Long-Term Investments	-	2	0.47	-	1.01	-
Other Long-Term Assets	19.23	1.63	3.3	2.01	0.57	0.54
Total Assets	1,196	1,435	635.35	352.18	351.02	183.45
Accounts Payable	6.11	5.85	6.55	6.88	3.42	3.49
Accrued Expenses	59.96	44.49	27.35	17.19	11.63	6.17
Current Portion of Leases	6.44	7.15	4.17	1.05	0.94	0.84
Current Unearned Revenue	1.64	2.18	2.06	2.24	-	-
Other Current Liabilities	-	0.01	3.82	0.36	-	-
Total Current Liabilities	74.16	59.68	43.94	27.72	16	10.49
Long-Term Leases	42.7	44.57	47.56	2.02	3.07	4.01
Long-Term Unearned Revenue	4.11	4.7	4.75	6.1	-	-
Other Long-Term Liabilities	2.89	0.83	-	-	0	0.02
Total Liabilities	123.86	109.79	96.25	35.85	19.07	14.53
Common Stock	2,365	2,276	1,192	759.43	607.58	336.51
Retained Earnings	-1,295	-952.11	-653.7	-439.17	-275.26	-167.61
Comprehensive Income & Other	2.08	0.96	0.98	-3.93	-0.38	0.03
Total Common Equity	1,072	1,325	539.11	316.33	331.94	168.92
Shareholders' Equity	1,072	1,325	539.11	316.33	331.94	168.92
Total Liabilities & Equity	1,196	1,435	635.35	352.18	351.02	183.45
Total Debt	49.14	51.72	51.73	3.08	4.01	4.85
Net Cash (Debt)	1,043	1,302	506.83	331.35	329.69	166.03
Net Cash Growth	28.76%	156.96%	52.96%	0.50%	98.57%	47.17%
Net Cash Per Share	11.19	16.12	8.73	6.37	8.58	5.45
Filing Date Shares Outstanding	94.89	93.05	69.6	53.91	47.78	33.03
Total Common Shares Outstanding	94.55	92.93	68.18	53.88	47.6	33
Working Capital	1,047	1,316	530.21	317.46	328.73	167
Book Value Per Share	11.34	14.26	7.91	5.87	6.97	5.12
Tangible Book Value	1,072	1,325	539.11	316.33	331.94	168.92
Tangible Book Value Per Share	11.34	14.26	7.91	5.87	6.97	5.12
Machinery	11.63	7.9	6.11	4.07	2.79	2.25
Leasehold Improvements	9.79	11.9	9.84	3.52	3.52	3.49

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q